PubMed:7543076
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-150 | Sentence | denotes | Lipopolysaccharide-induced E-selectin expression requires continuous presence of LPS and is inhibited by bactericidal/permeability-increasing protein. |
| T2 | 151-290 | Sentence | denotes | Endothelial cells stimulated by LPS express E-selectin, which plays an important role in mediating neutrophil adhesion during inflammation. |
| T3 | 291-593 | Sentence | denotes | E-selectin is induced within 1-2 h, peaks at 4-6 h, and gradually returns to basal level by 24 h. rBPI21, a recombinant N-terminal fragment of human bactericidal/permeability-increasing protein (BPI), inhibited LPS-induced E-selectin expression when added at the same time as, and up to 6 h after, LPS. |
| T4 | 594-699 | Sentence | denotes | Delayed administration of rBPI21 also affected LPS-mediated activation of the nuclear factor, NF-kappa B. |
| T5 | 700-880 | Sentence | denotes | Two to 4 h following LPS addition to endothelial cells, when NF-kappa B was already activated, addition of rBPI21 resulted in marked reduction of NF-kappa B detectable at 4 or 6 h. |
| T6 | 881-1072 | Sentence | denotes | These results indicate that endothelial activation requires continuous presence of LPS, and rBPI21 acts to reverse LPS-mediated endothelial activation by interrupting the on-going LPS signal. |
| T1 | 0-150 | Sentence | denotes | Lipopolysaccharide-induced E-selectin expression requires continuous presence of LPS and is inhibited by bactericidal/permeability-increasing protein. |
| T2 | 151-290 | Sentence | denotes | Endothelial cells stimulated by LPS express E-selectin, which plays an important role in mediating neutrophil adhesion during inflammation. |
| T3 | 291-593 | Sentence | denotes | E-selectin is induced within 1-2 h, peaks at 4-6 h, and gradually returns to basal level by 24 h. rBPI21, a recombinant N-terminal fragment of human bactericidal/permeability-increasing protein (BPI), inhibited LPS-induced E-selectin expression when added at the same time as, and up to 6 h after, LPS. |
| T4 | 594-699 | Sentence | denotes | Delayed administration of rBPI21 also affected LPS-mediated activation of the nuclear factor, NF-kappa B. |
| T5 | 700-880 | Sentence | denotes | Two to 4 h following LPS addition to endothelial cells, when NF-kappa B was already activated, addition of rBPI21 resulted in marked reduction of NF-kappa B detectable at 4 or 6 h. |
| T6 | 881-1072 | Sentence | denotes | These results indicate that endothelial activation requires continuous presence of LPS, and rBPI21 acts to reverse LPS-mediated endothelial activation by interrupting the on-going LPS signal. |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 27-37 | protein | denotes | E-selectin |
| T2 | 105-149 | protein | denotes | bactericidal/permeability-increasing protein |
| T3 | 151-168 | cell_type | denotes | Endothelial cells |
| T4 | 195-205 | protein | denotes | E-selectin |
| T5 | 250-260 | cell_type | denotes | neutrophil |
| T6 | 291-301 | protein | denotes | E-selectin |
| T7 | 389-395 | protein | denotes | rBPI21 |
| T8 | 399-430 | protein | denotes | recombinant N-terminal fragment |
| T9 | 434-484 | protein | denotes | human bactericidal/permeability-increasing protein |
| T10 | 486-489 | protein | denotes | BPI |
| T11 | 514-524 | protein | denotes | E-selectin |
| T12 | 620-626 | protein | denotes | rBPI21 |
| T13 | 672-686 | protein | denotes | nuclear factor |
| T14 | 688-698 | protein | denotes | NF-kappa B |
| T15 | 737-754 | cell_type | denotes | endothelial cells |
| T16 | 761-771 | protein | denotes | NF-kappa B |
| T17 | 807-813 | protein | denotes | rBPI21 |
| T18 | 846-856 | protein | denotes | NF-kappa B |
| T19 | 973-979 | protein | denotes | rBPI21 |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 0-48 | NP | denotes | Lipopolysaccharide-induced E-selectin expression |
| C3 | 81-84 | NP | denotes | LPS |
| C2 | 58-84 | NP | denotes | continuous presence of LPS |
| C4 | 105-149 | NP | denotes | bactericidal/permeability-increasing protein |
| C5 | 151-168 | NP | denotes | Endothelial cells |
| C6 | 183-186 | NP | denotes | LPS |
| C7 | 195-205 | NP | denotes | E-selectin |
| C8 | 207-212 | NP | denotes | which |
| C9 | 291-301 | NP | denotes | E-selectin |
| C10 | 389-395 | NP | denotes | rBPI21 |
| C12 | 434-490 | NP | denotes | human bactericidal/permeability-increasing protein (BPI) |
| C11 | 397-490 | NP | denotes | a recombinant N-terminal fragment of human bactericidal/permeability-increasing protein (BPI) |
| C13 | 502-535 | NP | denotes | LPS-induced E-selectin expression |
| C14 | 589-592 | NP | denotes | LPS |
| C15 | 620-626 | NP | denotes | rBPI21 |
| C16 | 668-686 | NP | denotes | the nuclear factor |
| C17 | 688-698 | NP | denotes | NF-kappa B |
| C18 | 737-754 | NP | denotes | endothelial cells |
| C19 | 761-771 | NP | denotes | NF-kappa B |
| C20 | 807-813 | NP | denotes | rBPI21 |
| C21 | 846-856 | NP | denotes | NF-kappa B |
| C23 | 964-967 | NP | denotes | LPS |
| C22 | 941-967 | NP | denotes | continuous presence of LPS |
| C24 | 973-979 | NP | denotes | rBPI21 |
| R1 | C6 | C3 | coref-ident | LPS,LPS |
| R2 | C8 | C7 | coref-relat | which,E-selectin |
| R3 | C9 | C7 | coref-ident | E-selectin,E-selectin |
| R4 | C12 | C4 | coref-ident | human bactericidal/permeability-increasing protein (BPI),bactericidal/permeability-increasing protein |
| R5 | C11 | C10 | coref-appos | a recombinant N-terminal fragment of human bactericidal/permeability-increasing protein (BPI),rBPI21 |
| R6 | C13 | C1 | coref-ident | LPS-induced E-selectin expression,Lipopolysaccharide-induced E-selectin expression |
| R7 | C14 | C6 | coref-ident | LPS,LPS |
| R8 | C15 | C10 | coref-ident | rBPI21,rBPI21 |
| R9 | C17 | C16 | coref-appos | NF-kappa B,the nuclear factor |
| R10 | C18 | C5 | coref-ident | endothelial cells,Endothelial cells |
| R11 | C19 | C16 | coref-ident | NF-kappa B,the nuclear factor |
| R12 | C20 | C15 | coref-ident | rBPI21,rBPI21 |
| R13 | C21 | C19 | coref-ident | NF-kappa B,NF-kappa B |
| R14 | C23 | C14 | coref-ident | LPS,LPS |
| R15 | C22 | C2 | coref-ident | continuous presence of LPS,continuous presence of LPS |
| R16 | C24 | C20 | coref-ident | rBPI21,rBPI21 |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-150 | Sentence | denotes | Lipopolysaccharide-induced E-selectin expression requires continuous presence of LPS and is inhibited by bactericidal/permeability-increasing protein. |
| S2 | 151-290 | Sentence | denotes | Endothelial cells stimulated by LPS express E-selectin, which plays an important role in mediating neutrophil adhesion during inflammation. |
| S3 | 291-388 | Sentence | denotes | E-selectin is induced within 1-2 h, peaks at 4-6 h, and gradually returns to basal level by 24 h. |
| S4 | 389-593 | Sentence | denotes | rBPI21, a recombinant N-terminal fragment of human bactericidal/permeability-increasing protein (BPI), inhibited LPS-induced E-selectin expression when added at the same time as, and up to 6 h after, LPS. |
| S5 | 594-699 | Sentence | denotes | Delayed administration of rBPI21 also affected LPS-mediated activation of the nuclear factor, NF-kappa B. |
| S6 | 700-880 | Sentence | denotes | Two to 4 h following LPS addition to endothelial cells, when NF-kappa B was already activated, addition of rBPI21 resulted in marked reduction of NF-kappa B detectable at 4 or 6 h. |
| S7 | 881-1072 | Sentence | denotes | These results indicate that endothelial activation requires continuous presence of LPS, and rBPI21 acts to reverse LPS-mediated endothelial activation by interrupting the on-going LPS signal. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-18 | lipid | denotes | Lipopolysaccharide |
| T2 | 27-37 | protein_molecule | denotes | E-selectin |
| T3 | 81-84 | lipid | denotes | LPS |
| T4 | 105-149 | protein_family_or_group | denotes | bactericidal/permeability-increasing protein |
| T5 | 151-168 | cell_type | denotes | Endothelial cells |
| T6 | 183-186 | lipid | denotes | LPS |
| T7 | 195-205 | protein_molecule | denotes | E-selectin |
| T8 | 250-260 | cell_type | denotes | neutrophil |
| T9 | 277-289 | other_name | denotes | inflammation |
| T10 | 291-301 | protein_molecule | denotes | E-selectin |
| T11 | 389-395 | protein_molecule | denotes | rBPI21 |
| T12 | 399-430 | protein_family_or_group | denotes | recombinant N-terminal fragment |
| T13 | 434-484 | protein_molecule | denotes | human bactericidal/permeability-increasing protein |
| T14 | 486-489 | protein_molecule | denotes | BPI |
| T15 | 502-505 | lipid | denotes | LPS |
| T16 | 514-524 | protein_molecule | denotes | E-selectin |
| T17 | 589-592 | lipid | denotes | LPS |
| T18 | 620-626 | protein_molecule | denotes | rBPI21 |
| T19 | 641-644 | lipid | denotes | LPS |
| T20 | 672-686 | protein_family_or_group | denotes | nuclear factor |
| T21 | 688-698 | protein_molecule | denotes | NF-kappa B |
| T22 | 721-724 | lipid | denotes | LPS |
| T23 | 737-754 | cell_type | denotes | endothelial cells |
| T24 | 761-771 | protein_molecule | denotes | NF-kappa B |
| T25 | 807-813 | protein_molecule | denotes | rBPI21 |
| T26 | 846-856 | protein_molecule | denotes | NF-kappa B |
| T27 | 909-931 | other_name | denotes | endothelial activation |
| T28 | 964-967 | lipid | denotes | LPS |
| T29 | 973-979 | protein_molecule | denotes | rBPI21 |
| T30 | 996-999 | lipid | denotes | LPS |
| T31 | 1052-1060 | other_name | denotes | on-going |
| T32 | 1061-1064 | lipid | denotes | LPS |